These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 18336331

  • 1. Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of Diphenidol: novel M4 muscarinic receptor antagonists.
    Varoli L, Angeli P, Buccioni M, Burnelli S, Fazio N, Marucci G, Recanatini M, Spampinato S.
    Med Chem; 2008 Mar; 4(2):121-8. PubMed ID: 18336331
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol.
    Varoli L, Angeli P, Buccioni M, Burnelli S, Cavalli A, Marucci G, Recanatini M.
    Farmaco; 2003 Sep; 58(9):651-7. PubMed ID: 13679157
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.
    Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD.
    J Med Chem; 2002 Jul 04; 45(14):3094-102. PubMed ID: 12086495
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of PCS1055, a novel muscarinic M4 receptor antagonist.
    Croy CH, Chan WY, Castetter AM, Watt ML, Quets AT, Felder CC.
    Eur J Pharmacol; 2016 Jul 05; 782():70-6. PubMed ID: 27085897
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.
    McNamara A, Pulido-Rios MT, Sweazey S, Obedencio GP, Thibodeaux H, Renner T, Armstrong SR, Steinfeld T, Hughes AD, Wilson RD, Jasper JR, Mammen M, Hegde SS.
    Eur J Pharmacol; 2009 Mar 01; 605(1-3):145-52. PubMed ID: 19168050
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.
    Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T.
    J Med Chem; 2000 Dec 28; 43(26):5017-29. PubMed ID: 11150173
    [Abstract] [Full Text] [Related]

  • 13. Selective antagonism activity of alkaloids from bulbs Fritillariae at muscarinic receptors: functional studies.
    Lin BQ, Ji H, Li P, Jiang Y, Fang W.
    Eur J Pharmacol; 2006 Dec 03; 551(1-3):125-30. PubMed ID: 17027747
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
    Dallanoce C, De Amici M, Barocelli E, Bertoni S, Roth BL, Ernsberger P, De Micheli C.
    Bioorg Med Chem; 2007 Dec 15; 15(24):7626-37. PubMed ID: 17889543
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.